Search Results - "Block TM"

Biotransformation research advances – 2023 year in review.

Authors: Khojasteh, S. Cyrus Argikar, Upendra A. Chatzopoulou, Maria et al.

Source: Drug Metabolism Reviews. Aug2024, Vol. 56 Issue 3, p190-222. 33p.

Detection and characterization of Hepatitis B virus double-stranded linear DNA-derived covalently closed circular DNA in chronic hepatitis B patients.

Authors: Liu, Hsin-Ni Kim, Elena Sun, Ning et al.

Source: PLoS Pathogens. 2/24/2026, Vol. 22 Issue 2, p1-19. 19p.

Complete genome and functional insights into Microbacterium sp. strain FBCC-B4120, a novel freshwater isolate with diverse biotechnological traits.

Authors: Kim, Jina Kim, Hyaekang Goh, Jaeduk et al.

Source: PLoS ONE. 5/7/2026, Vol. 21 Issue 5, p1-13. 13p.

Small molecule HBV RNA destabilizing drugs: Drugs of the future or compounds from the past?

Authors: Block TM Gotchev D Du Y

Source: Antiviral research [Antiviral Res] 2025 Dec; Vol. 244, pp. 106288. Date of Electronic Publication: 2025 Oct 09.

Publication Type: Journal Article; Review

Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8109699 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-9096 (Electronic) Linking ISSN: 01663542 NLM ISO Abbreviation: Antiviral Res Subsets: MEDLINE

Alternative splicing expands the antiviral IFITM repertoire in Chinese rufous horseshoe bats.

Authors: Mak, Nelly S.C. Liu, Jingyan Zhang, Dan et al.

Source: PLoS Pathogens. 12/26/2024, Vol. 20 Issue 12, p1-29. 29p.

HBV p22-interacting protein C1QBP inhibits viral replication through impeding nucleocapsid formation and nuclear import.

Authors: Peng, Xiao Liu, Cheng-Der Mitra, Bidisha et al.

Source: PLoS Pathogens. 10/17/2025, Vol. 21 Issue 10, p1-30. 30p.

A Double‐Blind, Placebo‐Controlled, Single‐Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HT‐101, an RNAi Therapeutic Targeting HBV Infection.

Authors: Zhang, Jianxiong Li, Jiangshuo Wu, Le et al.

Source: Clinical Pharmacology in Drug Development. Oct2025, Vol. 14 Issue 10, p754-763. 10p.

HBV capsid assembly modulators differentially modulate the assembly of wild-type and drug-resistant core protein chimeric nucleocapsids and empty capsids.

Authors: Liu, Hui Rimal, Hemraj Lyu, Jun et al.

Source: PLoS Pathogens. 8/5/2025, Vol. 21 Issue 8, p1-28. 28p.

Discovery of bimodal hepatitis B virus ribonuclease H and capsid assembly inhibitors.

Authors: Bradley, Daniel P. Valkner, Caleb J. Li, Qilan et al.

Source: PLoS Pathogens. 2/10/2025, Vol. 21 Issue 2, p1-22. 22p.

Experimentally Validated Design Principles of D‐Block Transition Metal Single‐Atom Non‐Dissociative Chemisorption Solid‐State Hydrogen Storage Materials.

Authors: Yue, Qiuyan Li, Chao Gao, Yong et al.

Source: Advanced Functional Materials; 11/26/2025, Vol. 35 Issue 48, p1-14, 14p

Continuous Serratus Posterior Superior Intercostal Plane Block for Salvage Mastectomy: A Case Report and Current Literature.

Authors: Baytar, Cagdas Koksal, Bengu Gulhan

Source: Medical Bulletin of Haseki / Haseki Tip Bulteni. Jan2026, Vol. 64 Issue 1, p69-72. 4p.

Manganese is a potent inducer of lysosomal activity that inhibits de novo HBV infection.

Authors: Yu, Lin Chang, Hao Xie, Wentao et al.

Source: PLoS Pathogens. 1/2/2025, Vol. 21 Issue 1, p1-31. 31p.

Analysis of the KAP3 subunit of kinesin-2 through cellular colocalization and immunoprecipitation studies reveals domain-specific attributes.

Authors: Arnouk, Maya Okland, Reese Heim, Laney et al.

Source: Bios (0005-3155). 2026, Vol. 97 Issue 2, p85-93. 9p.

Seroprevalence and risk factors of hepatitis B virus infection among healthcare workers in Africa: A systematic review and meta-analysis.

Authors: Berhanu, Leykun Desye, Belay Daba, Chala et al.

Source: PLoS ONE. 3/25/2025, Vol. 20 Issue 3, p1-25. 25p.

Identification of novel antiviral host factors by functional gene expression analysis using in vitro HBV infection assay systems.

Authors: Nosaka, Takuto Naito, Tatsushi Akazawa, Yu et al.

Source: PLoS ONE. 3/6/2025, Vol. 20 Issue 3, p1-20. 20p.

Host 3' flap endonuclease Mus81 plays a critical role in trimming the terminal redundancy of hepatitis B virus relaxed circular DNA during covalently closed circular DNA formation.

Authors: Zhang, Hu Long, Quanxin Liu, Yuanjie et al.

Source: PLoS Pathogens. 2/6/2025, Vol. 21 Issue 2, p1-37. 37p.

Sophora alopecuroides biflavones glycoside, isolated from Sophora alopecuroides, inhibits the secretion of hepatitis B virus surface antigen through direct interaction with its antigenic loop domain.

Authors: Wang, Ya Wang, Linlin Yang, Ge et al.

Source: Virology Journal. 10/27/2025, Vol. 22 Issue 1, p1-13. 13p.

Ultrasound-guided erector spinae plane block versus rhomboid intercostal sub-serratus plane block for postoperative analgesia in open radical nephrectomy: a randomized clinical study.

Authors: Eltwab, Doaa Abd Abed, Sayed M. Saad, Ahmad et al.

Source: BMC Anesthesiology. 10/22/2025, Vol. 25 Issue 1, p1-10. 10p.

Serological and virological characterization of hepatitis B surface antigen-positive patients with or without Helicobacter pylori co-infection at the university of Gondar comprehensive specialized hospital, Northwest Ethiopia.

Authors: Belayneh, Mekuriaw Tegegne, Bantayehu Addis Tizazu, Anteneh Mehari et al.

Source: BMC Infectious Diseases. 10/13/2025, Vol. 25 Issue 1, p1-10. 10p.

A single-cell digital PCR method tailored for quantification of HBV DNA positive cells in liver biopsy tissues.

Authors: Li, Jingmei Li, Hui Zhang, Xin et al.

Source: Journal of Translational Medicine. 10/10/2025, Vol. 23 Issue 1, p1-12. 12p.